prostate cancer 相關
廣告Achieve rapid isolation and purification of genomic and plasmid DNA. Buy Now. Extract high-quality DNA w/ excellent reproducibility for molecular biology experiments.
- SARS-CoV-2 Enrichment
Infectious, inactivated or VLPs.
Buy Now.
- SpeciMAX Saliva Test
Works With Any PCR Workflow.
Complete Solution For Testing.
- ChIP and RNA IP (RIP)
If you're doing ChIP, you should
use Dynabeads for IP
- MagMAX™ Viral/Pathogen
Recover RNA & DNA from a virus.
Kit utilizes magnetic-bead tech.
- High-Throughput Isolation
PureLink™ Pro 96 total RNA Kit.
Process more.
- Dynabeads Technology
Pioneer of magnetic separation
Range of Different Species
- SARS-CoV-2 Enrichment
上個月有 超過 1 萬 名用戶曾瀏覽 hindawi.com
European Journal of Cancer Care is an open access & peer-reviewed publication. Learn more. Maximize the impact, reach and visibility of your next paper – publish OA with Hindawi
搜尋結果
2023年2月13日 · BioXcel Therapeutics Announces Positive Full Data from Phase 2 Trial of BXCL701 in Rare, Aggressive Form of Prostate Cancer; to be Presented at 2023 ASCO Genitourinary Cancers Symposium
2024年4月29日 · INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune™ Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer. 04月29日 12:00 GlobeNewswire.
2 天前 · Approved for treatment of cancer-related bone disease and osteoporosis respectively Basel, May 22, 2024 – Sandoz, the global leader in generic and biosimilar medicines, today announced that the European Commission (EC) has granted marketing authorization for Wyost®1 (denosumab) and Jubbonti®2 (denosumab), the first and only biosimilar versions of reference medicines Xgeva®*3 and Prolia ...
2024年5月3日 · Racial Differences in Bladder Cancer Mortality Adjusting for Sociodemographic Disparities in a Statewide Cancer Registry Excess Death and Potential Life Years Lost Among Black Prostate Cancer Patients (1970-2020) Physician Density and Prostate Cancer
3 天前 · BioNTech will present an analysis of real-world data that investigated the overall survival, treatment patterns and prognostic variables of patients with testicular germ cell tumors receiving palliative chemotherapy.
2024年4月26日 · Multiple opportunities seen in other indications, including bladder and prostate cancers FAP is a substantially genetic orphan disease for which there are no approved therapeutic options; the current standard of care is surveillance and surgery
2024年5月5日 · Effectiveness Of The Medical Chatbot PROSCA To Inform Patients About Prostate Cancer: Results Of A Randomized Controlled Trial. Can We Predict IPSS Scores With Voiding Performance On Home-Based Uroflowmetry Data Using A Smartphone Application? A recording of the panel discussion is available to all press registrants.
